

QUICK LINKS
PHCCC has been shown to act as a group I metabotropic glutamate receptor antagonist with an IC50 of approximately 3 µM. This activity is 67 times more potent than (S)-4-carboxyphenylglycine (sc-203449). This compound has also demonstrated positive allosteric modulation for mGlu4a, potentiates L-AP4-mediated inhibition of striatopallidal synaptic transmission in vitro, and displays anti-Parkinsonian effects in rat models.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PHCCC, 10 mg | sc-361292 | 10 mg | $145.00 | |||
PHCCC, 50 mg | sc-361292A | 50 mg | $615.00 |